ATE342981T1 - Antikörper gegen den interferon-alpha/beta- rezeptor. - Google Patents

Antikörper gegen den interferon-alpha/beta- rezeptor.

Info

Publication number
ATE342981T1
ATE342981T1 AT97919622T AT97919622T ATE342981T1 AT E342981 T1 ATE342981 T1 AT E342981T1 AT 97919622 T AT97919622 T AT 97919622T AT 97919622 T AT97919622 T AT 97919622T AT E342981 T1 ATE342981 T1 AT E342981T1
Authority
AT
Austria
Prior art keywords
antibodies against
interferon alpha
beta receptor
receptor
interferon
Prior art date
Application number
AT97919622T
Other languages
English (en)
Inventor
Daniela Novick
Menachem Rubinstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE342981T1 publication Critical patent/ATE342981T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
AT97919622T 1996-05-01 1997-04-29 Antikörper gegen den interferon-alpha/beta- rezeptor. ATE342981T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11809696A IL118096A0 (en) 1996-05-01 1996-05-01 Antibodies against interferon alpha/beta receptor

Publications (1)

Publication Number Publication Date
ATE342981T1 true ATE342981T1 (de) 2006-11-15

Family

ID=11068814

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97919622T ATE342981T1 (de) 1996-05-01 1997-04-29 Antikörper gegen den interferon-alpha/beta- rezeptor.

Country Status (18)

Country Link
US (1) US6136309A (de)
EP (2) EP0927252B1 (de)
JP (1) JP4308322B2 (de)
KR (2) KR20000064953A (de)
CN (1) CN1198929C (de)
AT (1) ATE342981T1 (de)
AU (1) AU719995B2 (de)
BR (1) BR9709202A (de)
CA (1) CA2253239C (de)
DE (1) DE69736835T2 (de)
DK (1) DK0927252T3 (de)
EA (1) EA002543B1 (de)
ES (1) ES2274542T3 (de)
IL (2) IL118096A0 (de)
NO (1) NO324206B1 (de)
PT (1) PT927252E (de)
UA (1) UA76396C2 (de)
WO (1) WO1997041229A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563487A1 (de) * 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoklonale Antikörper gegen den Interferonrezeptor, mit neutralisierender Aktivität gegen Typ I-Interferon
US6713609B1 (en) 1996-07-16 2004-03-30 Genentech, Inc. Monoclonal antibodies to type I interferon receptor
US6376067B1 (en) * 1998-12-21 2002-04-23 Mitsubishi Polyester Film, Llc Silicone coated film with back side slip control coating and method of controlling slip of such film
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
JP4394350B2 (ja) * 2001-01-09 2010-01-06 ベイラー リサーチ インスティテュート 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ
AU2007202840B2 (en) * 2001-01-09 2011-07-28 Baylor Research Institute Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
UA76638C2 (en) * 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
AU2007203559B2 (en) * 2003-04-23 2010-09-02 E. R. Squibb & Sons, L.L.C. Compositions and methods for the therapy of inflammatory bowel disease
CA2522957C (en) 2003-04-23 2013-10-22 Medarex, Inc. Compositions and methods for the therapy of inflammatory bowel disease
PT2418220T (pt) 2003-12-10 2017-10-04 Squibb & Sons Llc Anticorpos contra interferão alfa e suas utilizações
ES2643237T3 (es) 2004-06-21 2017-11-21 E. R. Squibb & Sons, L.L.C. Anticuerpos del receptor 1 de interferón alfa y sus usos
US7888481B2 (en) * 2005-02-10 2011-02-15 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
EP1851248B1 (de) * 2005-02-10 2016-08-10 Baylor Research Institute Monoklonale anti-interferon-alpha-antikörper und verwendungsverfahren dafür
JP2008543335A (ja) * 2005-06-22 2008-12-04 ジェネンテック・インコーポレーテッド Ｉｆｎａｒ２を標的とするための方法と組成物
ES2549903T3 (es) * 2008-05-07 2015-11-03 Argos Therapeutics, Inc. Anticuerpos humanizados contra interferón alfa humano
CN103096927A (zh) 2010-07-15 2013-05-08 奥列格·伊里奇·爱泼斯坦 复合药物组合物以及治疗胃肠道功能性疾病或病症的方法
CA2804966A1 (en) 2010-07-15 2012-01-19 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
CN107074943B (zh) * 2016-07-14 2018-08-24 中国科学院生物物理研究所 I型干扰素受体抗体及其用途
CN115558027B (zh) * 2022-12-05 2023-02-28 北京万泰生物药业股份有限公司 一种核酸酶的单克隆抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563487A1 (de) * 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoklonale Antikörper gegen den Interferonrezeptor, mit neutralisierender Aktivität gegen Typ I-Interferon
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of interferon -alpha/beta binding protein
IL106591A (en) * 1992-09-03 2008-03-20 Yeda Res & Dev Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it
AU7782894A (en) * 1993-09-17 1995-04-03 Laboratoire Europeen De Biotechnologie S.A. Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon

Also Published As

Publication number Publication date
CN1220699A (zh) 1999-06-23
BR9709202A (pt) 1999-08-10
EP0927252B1 (de) 2006-10-18
JP4308322B2 (ja) 2009-08-05
DE69736835D1 (de) 2006-11-30
CN1198929C (zh) 2005-04-27
IL118096A0 (en) 1996-09-12
EP1739177A1 (de) 2007-01-03
KR20040075105A (ko) 2004-08-26
EA002543B1 (ru) 2002-06-27
CA2253239A1 (en) 1997-11-06
NO985050L (no) 1998-12-29
PT927252E (pt) 2007-01-31
IL126835A (en) 2007-07-24
KR100581798B1 (ko) 2006-05-25
UA76396C2 (en) 2006-08-15
JP2000509276A (ja) 2000-07-25
KR20000064953A (ko) 2000-11-06
DK0927252T3 (da) 2007-02-05
NO324206B1 (no) 2007-09-10
DE69736835T2 (de) 2007-11-22
ES2274542T3 (es) 2007-05-16
EP0927252A1 (de) 1999-07-07
AU719995B2 (en) 2000-05-18
WO1997041229A1 (en) 1997-11-06
EA199800968A1 (ru) 1999-04-29
HK1019339A1 (en) 2000-02-03
CA2253239C (en) 2010-08-10
NO985050D0 (no) 1998-10-29
US6136309A (en) 2000-10-24
AU2402797A (en) 1997-11-19

Similar Documents

Publication Publication Date Title
DE69736835D1 (de) Antikörper gegen den interferon-alpha/beta-rezeptor.
TR199700358A3 (tr) Interferon birlesimler.
MX9201749A (es) Proteina portadora.
MX9204396A (es) Antagonistas de arilo, amida, imida y carbamato piridina del factor activador de plaquetas.
FR2707297B1 (fr) Mélange silicone autoémulsifiable.
PT676413E (pt) Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao
ES1038575Y (es) Mesa perfeccionada.
FR2694283B1 (fr) Composition à base de soufre, moulable à chaud, et surfaçage réalisé au moyen de cette composition.
DE69101290D1 (de) Neigbares Fahrzeug.
ES1037062Y (es) Mesa de mezclas perfeccionada.
ES1033644Y (es) Mesa perfeccionada.
ES1029453Y (es) Conjunto de archivo automontable.
ES1033388Y (es) Juego de mesa perfeccionado.
ES1034508Y (es) Mochila escolar perfeccionada.
ES1034687Y (es) Mochila escolar perfeccionada.
ES1038353Y (es) Jeringuilla perfeccionada.
ES1033248Y (es) Conjunto modular de mesa convertible.
DE59300076D1 (de) Furazanylharnstoffe.
ES1035881Y (es) Mesa perfeccionada.
ES1036243Y (es) Tarima ensamblable perfeccionada.
ES1036403Y (es) Mesa.
ES1034176Y (es) Mesa plegable y poliposicionable perfeccionada.
ES1034233Y (es) Pistola aerografica perfeccionada.
ES1032042Y (es) Mesa multiuso poliposicionable perfeccionada.
ES1007863Y (es) Plataforma aspirante de pintado, perfeccionada.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0927252

Country of ref document: EP